Overall Fundamental outlook

Business Operations:

Sector: Basic Materials
Industry: Specialty Chemicals

Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India. The company operates in two segments, Chemicals and Hotel. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, and dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, acetonitrile, dimethylcarbonate, propylene glycol, and propylene carbonate. The company also provides derivatives comprising di-methyl acetamide, di-methyl amine hydrochloride, tri-methyl amine hydrochloride, di-ethyl amine hydrochloride, tri-ethyl amine hydrochloride, di-methyl urea, choline chloride, mono-ethyl amine hydrochloride, and benzyl tri ethyl ammonium chloride; and pharma excipients, such as poly vinyl pyrrolidone. In addition, it operates Balaji Sarovar Premiere, a hotel in Solapur, Maharashtra, as well as engages in the provision of hotel, restaurant, and hospitality services. The company serves pharmaceutical, agrochemical, paint and resin, animal feed, oil and gas, rubber cleaning chemical, dye and textile, pesticides and insecticides, water treatment chemical, optical brighteners, corrosion inhabitations, cosmetics, explosives, and foundry chemicals industries. It also exports its products to the United States, the United Kingdom, Argentina, Latin America, Canada, Israel, Australia, Bangladesh, Germany, Italy, Egypt, South Africa, and internationally. Balaji Amines Limited was incorporated in 1988 and is headquartered in Solapur, India.

Revenue projections:

Revenue projections for BALAMINES
Revenue projections for BALAMINES

Revenues for BALAMINES are expected to drop compared to the previous year, which could be a cause for concern for investors. A decline in earnings may negatively impact the company's profitability, leading cautious investors to reconsider their positions, as it often signals challenges in overall financial health.

Financial Ratios:

currentRatio 2.34000
forwardPE 27.41047
debtToEquity 6.19400
earningsGrowth 0.61700
revenueGrowth 0.11900
grossMargins 0.43619
operatingMargins 0.20990
trailingEps 51.52000
forwardEps 72.60000

BALAMINES's current ratio of 2.34 reflects its strong liquidity position. The company has enough cash reserves and current assets to service its short-term debt obligations, signaling that BALAMINES is financially well-prepared to meet its liabilities without difficulty.
BALAMINES's Forward PE being in a good range suggests that its stock price is aligned well with earnings. The stock is not considered overpriced, offering room for future growth, which makes it an appealing investment opportunity with the potential for value appreciation.
With positive earnings and revenue growth, Balaji Amines Limited is on a path to expand its business. This strong financial performance suggests the company will continue to grow, as increasing profits and revenue highlight a healthy outlook.
Positive gross and operating margins for Balaji Amines Limited suggest that the company is operating profitably. These margins highlight Balaji Amines Limited's efficiency in managing costs while maintaining healthy revenue streams, contributing to its overall financial strength.
BALAMINES's forward EPS being higher than its trailing EPS indicates that the company is expected to achieve greater profitability this financial year. This suggests improving earnings and a stronger financial position compared to the previous year's performance.

Price projections:

Price projections for BALAMINES
Price projections for BALAMINES

Surpassing the higher limit of projections, BALAMINES's stock price reflects significant gains. Yet, the restricted potential for further rises indicates that the stock may need to consolidate, possibly leading to increased volatility in the short term.

Recommendation changes over time:

Recommendations trend for BALAMINES
Recommendations trend for BALAMINES


The recent buy bias from analysts suggests BALAMINES is seen as a strong investment, encouraging more investors to consider it. With this favorable sentiment, BALAMINES appears to be a reliable option for parking money, offering stability and long-term growth potential in the stock market.